FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes compounds of the formula (I) where a substituent Z means -Ar1,-Ar1-Ar2,-Ar1-O-Ar2,-Ar1-(CH2)1-20-Ar2, where substituents Ar1 and Ar2 are taken independently from a group involving phenyl, dibenzofuryl, pyridinyl and substituents Ar1 and Ar2 can be substituted independently with nitro-, C1-20-alkyl-, C3-8-cycloalkyl-groups; fragment A means a bridge group and p = 2. Compounds of the formula (I) inhibit cholesterol absorption from enteric tract and inhibit activity of enzymes - cholesterol ester hydrolase and acyl-CoA-cholesterol acyltransferase and therefore compounds can be used for treatment of patients with atherosclerosis, familial hypercholesterolemia, hyperlipidemia and similar diseases. EFFECT: enhanced effectiveness of the composition. 14 cl, 1 tbl, 42 ex
Title |
Year |
Author |
Number |
C-22 STABILIZED DERIVATIVES OF RAPAMYCIN, METHOD OF IMMUNO- -SUPPRESSION INDUCING, METHOD OF TREATMENT AND PROPHYLAXIS OF TRANSPLANT REJECTION OR HOMOLOGOUS DISEASE, METHOD OF TREATMENT OR PROPHYLAXIS OF HYPERPROLIFERATIVE VASCULAR DISORDER |
1994 |
|
RU2152946C1 |
SUBSTITUTED PYRIMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR N-OXIDES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1992 |
- Dzhon Vatson Ehllingboj
- Madelen Nikajdo
- Zhak Framros Bazhli
|
RU2113437C1 |
AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-E]-INDOLE-8-ONE COMPOUNDS AND METHOD OF TREATMENT |
1996 |
- Stehk Gehri Pol
- M'Jusho Richard Ehrik
- Bravo Bajron Abel'
- Kang Jang Khi
|
RU2178416C2 |
METHOD OF SYNTHESIS OF [2-((8,9)-DIOXO-2,6-DIAZOBI-CYCLO-[5,2,0]NON-1(7)-EN-2-YL)ETHYL]PHOSPHONIC ACID, METHOD OF SYNTHESIS OF N-[3-(TERTIARY BUTYLOXY- CARBONYLAMINO)PROPYL]-2-AMINOETHYLPHOSPHONIC ACID DI-C-C-ALKYL ESTER, COMPOUNDS |
1998 |
- Asselin Andre Al'Fred
- Kinni Uill'Jam Ehlvin
- Shmid Dzhin
|
RU2205834C2 |
RAPAMYCIN ESTERS |
1996 |
|
RU2160739C2 |
RAPAMYCIN DERIVATIVES, A PHARMACEUTICAL COMPOSITION AND A METHOD OF IMMUNODEPRESSION STIMULATING |
1993 |
- Venling Kao
- Magid A.Abou-Gkharbia
- Robert L.Vogel
|
RU2126409C1 |
DERIVATIVES OF SUBSTITUTED BENZOYLBENZENE-, BIPHENYL OR 2-OXAZOLEALKANOIC ACID OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS, AND A METHOD OF THEIR SYNTHESIS |
1992 |
- Amedeo Arturo Fejlli[Us]
- Ehntoni Frehnk Kreft Iii[Us]
- Dzhon Genri Musser[Us]
|
RU2037481C1 |
DERIVATIVES OF SPIRO-[ISOQUINOLINE-4-(1H)-3-PYRROLIDINE]-1,2',3,5'-(2H)-TETR- -ONE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION USED FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS-RELATED COMPLICATIONS |
1991 |
- Majkl Sotirios Malamas[Gr]
|
RU2110518C1 |
DERIVATIVES OF [([2- (AMINO -3,4-DIOXO -1-CYCLOBUTENE -1-YL)AMINO]ALKYL)] ACIDS |
1992 |
- Uil'Jam Alvin Kinni[Us]
- Dinna Kolett Garrison[Us]
|
RU2039035C1 |
RAPAMYCIN HYDROXYESTERS, METHOD OF THEIR SYNTHESIS AND METHODS OF TREATMENT |
1995 |
- Dzheral'D Stenli Skotnitski
- Kristina Luiza Leon
- Gaj Alan Shizer
|
RU2134267C1 |